IN THIS ISSUE

Bob Kirsch
Health insurance plans need only bolster the following accepted guidelines to see a return on a very little bit of investment
Peer-Reviewed
Michael Toscani, PharmD
Marc Riedl, MD, MS
With the advent of new disease-specific agents, some patients with HAE may find relief from its enormous physical and psychological toll
Legislation & Regulation
John Carroll
In the long run, health plans will benefit from the new rules. In the short run, hospitals say they already have enough economic pressures.
Medication Management
Thomas Reinke
Expect more denials as more specialty drugs are introduced and prescribed
Tomorrow's Medicine
Thomas Morrow, MD
For this condition that is largely confined to the Medicare population, a new treatment is now available
News and Commentary